DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01)
Clinical trial NCT03384940 · COMPLETED
Trial details
- NCT number
- NCT03384940
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-23
- Primary completion
- 2019-08-09
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.